** Medical imaging software provider Pro Medicus PME.AX gains 1.6% to A$257.85; set for its biggest intraday pct gain since Jan. 9
** Jefferies retains "hold"; raises PT to A$250
** Says co can secure significant earnings growth despite lofty ~A$250/shr valuation, implying 98% U.S. radiology market penetration and demanding near-total market dominance for support
** Revises FY26-27 earnings to 13%-32% ahead of consensus; sees fair value of PME at A$140, implying ~50% U.S. market share
** Says existing customers, such as NYU Langone and Duke University, upgrading to full range of services may boost rev by 24%
** Adds PME's Visage viewer tech outshines newly launched DeepHealth OS Fast Viewer by California-based Radnet RDNT.O
** Stock rated "hold" on avg; median PT is A$237.50 – LSEG
** PME more than doubled in value last year, gaining 161%
(Reporting by Kumar Tanishk in Bengaluru)
((Tanishk.Kumar@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。